---
title: "The Win Ratio and Beyond"
subtitle: "Evolution, Applications, and Open Questions in Composite Endpoint Analysis"
css: wr_sj_style.css
csl: apa.csl
author:
  name: Lu Mao
  affiliations: 
    - name: Department of Biostatistics & Medical Informatics
    - University of Wisconsin-Madison
  email: lmao@biostat.wisc.edu
format: 
  revealjs:
    theme: simple
    # incremental: true   
editor: visual
include-in-header:
  - text: |
      <style type="text/css">
      ul li ul li {
        font-size: 0.80em;
      }
      </style>
bibliography: references.bib
title-slide-attributes:
  data-background-image: sj_images/banner.webp
  data-background-size: 35%
  data-background-position: 0% 2%
---

## Outline

-   **Background**

-   **Censoring's impact on estimand**

    -   Time frame of comparison

-   **Two approaches to clarity**

    -   **Nonparametric**: fix the time frame
    -   **Semiparametric**: posit a time-constant feature

-   **Summary and discussion**

$$
\def\a{{(a)}}
\def\b{{(1-a)}}
\def\t{{(1)}}
\def\c{{(0)}}
\def\d{{\rm d}}
\def\T{{\rm T}}
$$

# Introduction

## Composite Endpoint

-   **Traditional composite endpoint**
    -   **Time to first event**
        -   Major adverse cardiac event (MACE): death, heart failure, myocardio-infarction, stroke, etc.
    -   **Limitations**:
        -   Lack of clinical priority
        -   Statistical inefficiency (waste of data)
-   **Hierarchical composite endpoint (HCE)**
    -   **Example**: Death \> nonfatal MACE \> six-minute walk test (6MWT)/NYHA class

## Win Ratio: Basics

-   **A common approach to HCE**
    -   **Proposed and popularized** by @pocock2012
    -   **Treatment vs control**: generalized pairwise comparisons [@buyse2010]
    -   **Win-loss**: sequential comparison on components
        -   Longer survival \> fewer/later nonfatal MACE \> better 6MWT/NYHA score
    -   **Effect size**: WR $=$ wins / losses
-   **Alternative metrics**
    -   **Proportion in favor** (net benefit): PIF $=$ wins $-$ losses
    -   **Win odds**: WO $=$ (wins $+$ $2^{-1}$ties) / (losses $+$ $2^{-1}$ties)


## Prioritized Comparison
<div style="font-size: 0.75em; line-height: 1.2em;">
Cut off at earlier end of follow-up
</div>
![](sj_images/comp_wr_pc.png){width="50%" fig-align="center"}

## Pairwise Comparison

:::: {.columns}
::: {.column width="30%"}
<div style="font-size: 0.75em; line-height: 1.2em;">
- **GPC Results** 
    - Wins: 8 / 16 = 50%  
    - Losses: 3 / 16 = 18.8%
    - Ties: 5 / 16 = 31.2%
- **Effect Sizes**
    - WR = 50% / 18.8% = 2.67  
    - PIF = 50% - 18.8% = 31.2%
    - WO = (50% + 15.6%) / (18.8% + 15.6%) = 1.72
</div>
:::

::: {.column width="70%"}
<br>

![](sj_images/gpc_pairwise.png){width="100%" fig-align="center"}
:::
::::


## Stratification


# Properties and Use Cases


# Extensions and Variations

## Sample Size Calculation


## Regression Analysis

## Win-Loss Times

## DOOR


# Challenges and Open Questions

## Criticisms

## Acknowledgments

-   **Funding**

    -   [R01HL149875](https://reporter.nih.gov/search/9aSu5u3xlE26GrjbF_4cBg/project-details/10734551) (11/2019 -- 7/2028)
    -   [DMS2015526](https://www.nsf.gov/awardsearch/showAward?AWD_ID=2015526) (7/2020 -- 6/2024) ![](images/funds.png){fig-align="center" width="70%"}

-   **Collaborators**

    -   [KyungMann Kim](https://biostat.wiscweb.wisc.edu/staff/kim-kyungmann/), [Tuo Wang](https://tuowang.rbind.io/), Gaohong Dong, Bo Huang, etc.

## References
